2022-11-01
Our company has been selected for the "U.S. Life Science Market Development Support Program 2022" sponsored by the Yokohama City
Our company has been selected for the "U.S. Life Science Market Development Support Program 2022" sponsored by the Yokohama City Americas Office. With the support of our program partner, Kievit Scientific, we will begin preparation to enter U.S. market. https://kievitsci.com/
2024-12-24
CoreTissue BioEngineering announces the renewal of its corporate website
2024-11-11
Yoji Jokura will present at ”The 62nd Annual Meeting of the Japanese Society for Artificial Organs”
2024-10-15
CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation